Browse regulatory pathways
Open a country and device class to see local representative rules, planning timelines, submission steps, and request-first market entry packages.
GHMAP Resources
Healthcare market access resources
Educational resources for healthcare market access, source status, professional review, and structured workflows.
Regulatory pathways
Country × device-class pathway pages
Structured BLUF overviews for TİTCK, SFDA, MOHAP, SAHPRA, NAFDAC, EU MDR, MHRA, FDA 510(k), and Health Canada — illustrative until sources are verified.
Blog
Practical pathway articles for manufacturers
Start with CE Mark vs FDA 510(k) — a calm comparison of first-market sequencing for medical device companies.
CE Mark vs FDA 510(k)
How the two pathways differ in evidence expectations, sequencing, and what has to be confirmed locally before either is treated as settled.
Frequently asked
Market-access questions, answered plainly
General educational answers. They are not jurisdiction-specific conclusions and do not replace professional review.
What is healthcare market access?
Healthcare market access is the work of understanding how a product may move through regulatory, reimbursement, payer, evidence, procurement, and launch-readiness questions in a market.
Why does source status matter?
Source status helps teams separate verified inputs from placeholders, outdated material, examples, or items that still require professional review.
Can GHMAP replace professional review?
No. GHMAP organizes market-access intelligence for planning and review. It does not replace qualified regulatory, reimbursement, legal, clinical, commercial, or local-market professionals.
Glossary
Key market-access terms.
Source status
A label showing whether information is source required, to verify, reviewed, outdated, or example only.
Evidence gap
A missing or insufficient evidence item that may need review before planning decisions.
Confidence level
A planning label based on source quality, recency, jurisdiction match, corroboration, and review status.
Professional review
Qualified expert review before market-access content is used for business planning.
Using GHMAP
How to read a GHMAP brief.
A GHMAP brief is structured to make source and review status visible at a glance. Follow these steps before acting on any field.
Check the source status first
Every field in a GHMAP brief carries a source status — Source required, To verify, Reviewed, or Outdated. Do not rely on any field marked Source required or Outdated for planning decisions.
Read the confidence level
Confidence is a planning label based on source quality, recency, jurisdiction match, and corroboration. Low confidence means the field needs professional review before it influences strategy.
Note the evidence gaps
Evidence gaps flag missing or insufficient items the reviewer could not resolve from available sources. Each gap is a known unknown — track it, assign it, and do not assume it away.
Identify fields flagged for professional review
Regulatory pathways, reimbursement routes, pricing frameworks, and legal questions are flagged as requiring qualified professional review. These flags are not optional — they exist because the question cannot be responsibly answered without a specialist.
Act on the next actions column
Each country dashboard row lists a next action. These are the concrete steps required before the field can be marked Reviewed: attach a source, assign a reviewer, or complete a verification step.
Want to see a real example? View the sample brief →
Your next market is one introduction away.
Tell us your product, target country, and current stage. We will review the context and identify the right next conversation.
Start Your First Market Access ProjectProfessional review is required before business use. Do not submit patient data.